Rockwell Medical Share Price Today
(NASDAQ: RMTI)

Name: Rockwell Medical Share Price Today (NASDAQ: RMTI) - Rockwell Medical Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Rockwell Medical share price is $1.65 & ₹143.50 as on 6 Mar 2025, 2.30 'hrs' IST

$1.65

▲

0.04

(2.48%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Rockwell Medical share price in Dollar and Rupees. Guide to invest in Rockwell Medical stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Rockwell Medical, along with analyst recommendations, forecasts, and comprehensive financials.

Rockwell Medical share price movements

Today's Low: $1.59
Today's High: $1.66
$1.65
3.64%
Downside
Day's Volatility :3.93%
Upside
0.3%
52 Weeks Low: $1.35
52 Weeks High: $5.15
$1.65
18.18%
Downside
52 Weeks Volatility :73.79%
Upside
67.96%

Rockwell Medical (RMTI) Returns

Period	Rockwell Medical Inc	Index (Russel 2000)
3 Months	-24.31%	0.0%
6 Months	-45.72%	0.0%
1 Year	10.0%	0.0%
3 Years	-51.61%	-11.6%

Rockwell Medical (RMTI) Key Statistics

in dollars & INR

Previous Close	$1.61
Open	$1.61
Today's High	$1.655
Today's Low	$1.59
Market Capitalization	$52.0M
Today's Volume	$98.1K
52 Week High	$5.15
52 Week Low	$1.35
Revenue TTM	$98.9M
EBITDA	$2.8M
Earnings Per Share (EPS)	$-0.04
Profit Margin	-1.25%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-4.88%

How to invest in Rockwell Medical Stock (RMTI) from India?

It is very easy for Indian residents to invest directly in Rockwell Medical from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Rockwell Medical stock in both Indian Rupees (INR) and US Dollars (USD). Search for Rockwell Medical or RMTI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Rockwell Medical or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Rockwell Medical shares which would translate to 0.527 fractional shares of Rockwell Medical as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Rockwell Medical, in just a few clicks!

Returns in Rockwell Medical (RMTI) for Indian investors in Rupees

The Rockwell Medical stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Rockwell Medical investment value today

Current value as on today

₹1,14,949

Returns

₹14,949

(+14.95%)

Returns from Rockwell Medical Stock

₹10,000 (+10%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Rockwell Medical (RMTI)

-78%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Rockwell Medical Stock from India on INDmoney has decreased by -78% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Rockwell Medical

Armistice Capital, LLC
9.42%
Vanguard Group Inc
3.73%
GlobeFlex Capital, L.P.
2.30%
Marshall Wace Asset Management Ltd
1.85%
Renaissance Technologies Corp
1.37%
Geode Capital Management, LLC
0.99%

Analyst Recommendation on Rockwell Medical

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Rockwell Medical(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Rockwell Medical Stock (RMTI)

What analysts predicted

Upside of 293.94%

Target:

$6.50

Current:

$1.65

Insights on Rockwell Medical Stock (Ticker Symbol: RMTI)

Price Movement
In the last 6 months, RMTI stock has moved down by -44.6%
Increasing Revenue
Revenue is up for the last 4 quarters, 22.09M → 28.31M (in $), with an average increase of 7.9% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -1.73M → 1.66M (in $), with an average increase of 342.0% per quarter
RMTI vs ITCI (1 yr)
In the last 1 year, Intra-cellular Therapies, Inc. has given 98.7% return, outperforming this stock by 88.7%
RMTI vs ITCI (3 yr)
In the last 3 years, Intra-cellular Therapies, Inc. has given 138.1% return, outperforming this stock by 191.2%
Price to Sales
ForRMTI every $1 of sales, investors are willing to pay $0.5, whereas for Intra-cellular Therapies, Inc., the investors are paying $19.9 for every $1 of sales.

RMTI Rockwell Medical Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$63.4M	↑ 10.63%
Net Income	$-32.1M	↑ 23.94%
Net Profit Margin	-50.68%	↓ 5.44%

	FY19	Y/Y Change
Revenue	$61.3M	↓ 3.29%
Net Income	$-31.1M	↓ 3.26%
Net Profit Margin	-50.7%	↓ 0.02%

	FY20	Y/Y Change
Revenue	$62.2M	↑ 1.46%
Net Income	$-31.9M	↑ 2.75%
Net Profit Margin	-51.34%	↓ 0.64%

	FY21	Y/Y Change
Revenue	$61.9M	↓ 0.43%
Net Income	$-35.0M	↑ 9.71%
Net Profit Margin	-56.57%	↓ 5.23%

	FY22	Y/Y Change
Revenue	$72.8M	↑ 17.57%
Net Income	$-20.6M	↓ 41.26%
Net Profit Margin	-28.26%	↑ 28.31%

	FY23	Y/Y Change
Revenue	$83.6M	↑ 14.84%
Net Income	$-8.4M	↓ 58.99%
Net Profit Margin	-10.09%	↑ 18.17%

	Q2 FY23	Q/Q Change
Revenue	$18.1M	↓ 8.07%
Net Income	$-3.3M	↑ 34.35%
Net Profit Margin	-18.28%	↓ 5.77%

	Q3 FY23	Q/Q Change
Revenue	$23.8M	↑ 31.48%
Net Income	$-1.9M	↓ 43.36%
Net Profit Margin	-7.88%	↑ 10.4%

	Q4 FY23	Q/Q Change
Revenue	$22.1M	↓ 7.06%
Net Income	$-1.5M	↓ 19.23%
Net Profit Margin	-6.84%	↑ 1.04%

	Q1 FY24	Q/Q Change
Revenue	$22.7M	↑ 2.64%
Net Income	$-1.7M	↑ 14.48%
Net Profit Margin	-7.63%	↓ 0.79%

	Q2 FY24	Q/Q Change
Revenue	$25.8M	↑ 13.92%
Net Income	$343.0K	↓ 119.82%
Net Profit Margin	1.33%	↑ 8.96%

	Q3 FY24	Q/Q Change
Revenue	$28.3M	↑ 9.62%
Net Income	$1.7M	↑ 385.13%
Net Profit Margin	5.88%	↑ 4.55%

	FY18	Y/Y Change
Profit	$-1.6M	↓ 142.8%

	FY19	Y/Y Change
Profit	$2.8M	↓ 279.17%

	FY20	Y/Y Change
Profit	$2.7M	↓ 4.01%

	FY21	Y/Y Change
Profit	$-2.4M	↓ 188.81%

	FY22	Y/Y Change
Profit	$4.1M	↓ 268.47%

	FY23	Y/Y Change
Profit	$8.7M	↑ 113.49%

	Q2 FY23	Q/Q Change
Profit	$1.0M	↓ 60.25%

	Q3 FY23	Q/Q Change
Profit	$2.2M	↑ 113.17%

	Q4 FY23	Q/Q Change
Profit	$2.9M	↑ 30.34%

	Q1 FY24	Q/Q Change
Profit	$3.1M	↑ 6.76%

	Q2 FY24	Q/Q Change
Profit	$4.6M	↑ 48.5%

	Q3 FY24	Q/Q Change
Profit	$6.2M	↑ 37.12%

	FY18	Y/Y Change
Operating Cash Flow	$-20.4M	↓ 3.29%
Investing Cash Flow	$12.7M	↓ 12.27%
Financing Cash Flow	$22.0M	↓ 1116.97%

	FY19	Y/Y Change
Operating Cash Flow	$-27.3M	↑ 33.47%
Investing Cash Flow	$-4.7M	↓ 137.33%
Financing Cash Flow	$21.1M	↓ 4.17%

	FY20	Y/Y Change
Operating Cash Flow	$-29.6M	↑ 8.76%
Investing Cash Flow	$3.2M	↓ 167.62%
Financing Cash Flow	$63.3M	↑ 200.29%

	FY21	Y/Y Change
Operating Cash Flow	$-33.5M	↑ 13.13%
Investing Cash Flow	$311.0K	↓ 90.32%
Financing Cash Flow	$-2.2M	↓ 103.44%

	FY22	Y/Y Change
Operating Cash Flow	$-17.4M	↓ 48.07%
Investing Cash Flow	$-2.4M	↓ 870.42%
Financing Cash Flow	$16.6M	↓ 863.29%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-1.7M	↓ 55.11%
Investing Cash Flow	$-64.0K	↓ 101.21%
Financing Cash Flow	$-130.0K	↓ 79.4%

Rockwell Medical Technicals Summary

Sell

Neutral

Buy

Rockwell Medical is currently in a neutral trading position according to technical analysis indicators.

Rockwell Medical (RMTI) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Rockwell Medical Inc	-19.9%	-45.72%	10.0%	-51.61%	-95.31%
Intra-cellular Therapies, Inc.	3.38%	81.15%	98.68%	146.46%	588.66%
Haleon Plc Spon Ads	10.71%	2.13%	26.53%	42.24%	42.24%
Zoetis Inc.	-3.04%	-10.5%	-9.01%	-11.21%	28.74%
Neurocrine Biosciences Inc.	-25.31%	-6.07%	-13.91%	29.45%	28.72%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Rockwell Medical Inc	NA	NA	-0.79	0.0	-0.05	0.01	NA	0.9
Intra-cellular Therapies, Inc.	NA	NA	0.0	0.13	-0.09	-0.07	NA	10.81
Haleon Plc Spon Ads	26.35	26.35	1.92	0.36	0.09	0.04	0.02	1.8
Zoetis Inc.	31.17	31.17	3.01	6.07	0.51	0.15	0.01	10.64
Neurocrine Biosciences Inc.	34.6	34.6	0.27	6.44	0.14	0.1	NA	26.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Rockwell Medical Inc	Buy	$52.0M	-95.31%	NA	-1.25%
Intra-cellular Therapies, Inc.	Buy	$14.0B	588.66%	NA	-10.97%
Haleon Plc Spon Ads	Buy	$47.7B	42.24%	26.35	12.84%
Zoetis Inc.	Buy	$76.1B	28.74%	31.17	26.86%
Neurocrine Biosciences Inc.	Buy	$11.4B	28.72%	34.6	14.49%

About Rockwell Medical

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. Also, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Organization	Rockwell Medical
Employees	237
CEO	Dr. Mark Strobeck Ph.D.
Industry	Health Technology

Management People of Rockwell Medical

Name	Title
Dr. Mark Strobeck Ph.D.	President, CEO & Director
Mr. Jesse Neri	Senior VP & CFO
Ms. Megan C. Timmins	Executive VP, Chief Legal Officer & Secretary
Mr. Timothy T. Chole	Senior VP & Chief Commercial Officer
Ms. Heather R. Hunter	Senior VP & Chief Corporate Affairs Officer

Important FAQs about investing in RMTI Stock from India :

What is Rockwell Medical share price today?

Rockwell Medical share price today stands at $1.65, Open: $1.61 ; Previous Close: $1.61 ; High: $1.66 ; Low: $1.59 ; 52 Week High: $5.15 ; 52 Week Low: $1.35.

The stock opens at $1.61, after a previous close of $1.61. The stock reached a daily high of $1.66 and a low of $1.59, with a 52-week high of $5.15 and a 52-week low of $1.35.

Can Indians buy Rockwell Medical shares?

Yes, Indians can invest in the Rockwell Medical (RMTI) from India.

With INDmoney, you can buy Rockwell Medical at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Rockwell Medical at zero transaction cost.

How can I buy Rockwell Medical shares from India?

It is very easy to buy Rockwell Medical from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Rockwell Medical (RMTI) be purchased?

Yes, you can buy fractional shares of Rockwell Medical with INDmoney app.

What are the documents required to start investing in Rockwell Medical stocks?

To start investing in Rockwell Medical, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.